Aoxin Q & M Dental Group Past Earnings Performance
Past criteria checks 0/6
Aoxin Q & M Dental Group's earnings have been declining at an average annual rate of -47%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 5.8% per year.
Key information
-47.0%
Earnings growth rate
-39.5%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 5.8% |
| Return on equity | -17.7% |
| Net Margin | -26.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Aoxin Q & M Dental Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 178 | -47 | 2 | 0 |
| 30 Sep 23 | 167 | -56 | 2 | 0 |
| 30 Jun 23 | 155 | -65 | 2 | 0 |
| 31 Mar 23 | 148 | -67 | 2 | 0 |
| 31 Dec 22 | 140 | -68 | 2 | 0 |
| 30 Sep 22 | 142 | -36 | 3 | 0 |
| 30 Jun 22 | 143 | -5 | 3 | 0 |
| 31 Mar 22 | 152 | -6 | 3 | 0 |
| 31 Dec 21 | 160 | -7 | 2 | 0 |
| 30 Sep 21 | 164 | -8 | 2 | 0 |
| 30 Jun 21 | 167 | -8 | 2 | 0 |
| 31 Mar 21 | 150 | -10 | 2 | 0 |
| 31 Dec 20 | 134 | -12 | 2 | 0 |
| 30 Sep 20 | 130 | -16 | 3 | 0 |
| 30 Jun 20 | 125 | -18 | 3 | 0 |
| 31 Mar 20 | 135 | -15 | 3 | 0 |
| 31 Dec 19 | 141 | -14 | 3 | 0 |
| 30 Sep 19 | 130 | -12 | 6 | 0 |
| 30 Jun 19 | 124 | -10 | 7 | 0 |
| 31 Mar 19 | 121 | -5 | 9 | 0 |
| 31 Dec 18 | 119 | 0 | 11 | 0 |
| 30 Jun 18 | 113 | 7 | 8 | 0 |
| 31 Mar 18 | 105 | 6 | 7 | 0 |
| 31 Dec 17 | 101 | 5 | 6 | 0 |
| 30 Sep 17 | 100 | 4 | 4 | 0 |
| 30 Jun 17 | 96 | 1 | 7 | 0 |
| 31 Mar 17 | 91 | 1 | 6 | 0 |
| 31 Dec 16 | 87 | 1 | 6 | 0 |
| 30 Sep 16 | 75 | 1 | 8 | 0 |
| 31 Dec 15 | 46 | 1 | 3 | 0 |
| 31 Dec 14 | 25 | -1 | 2 | 0 |
| 31 Dec 13 | 0 | -4 | 0 | 0 |
Quality Earnings: 1D4 is currently unprofitable.
Growing Profit Margin: 1D4 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1D4 is unprofitable, and losses have increased over the past 5 years at a rate of 47% per year.
Accelerating Growth: Unable to compare 1D4's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1D4 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-2%).
Return on Equity
High ROE: 1D4 has a negative Return on Equity (-17.71%), as it is currently unprofitable.